ArticleAdvances in radiation oncology2026

Radioenhancing Hafnium Oxide Nanoparticles (NBTXR3) Followed by Stereotactic Body Radiation Therapy in Patients With Hepatocellular Carcinoma and Liver Metastases (NBTXR3-103): Phase 1 Dose-Escalation Trial.

Enrique Chajon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.